This website is intended for healthcare professionals only.
Dr Nicola Gökbuget
GOETHE UNIVERSITY HOSPITAL, UNIVERSITY CANCER CENTER
FRANKFURT, GERMANY
About Our Speaker
She is also a principal investigator of the German Consortium for Translational Cancer Research and the Frankfurt Cancer Institute, a board member of the German and European LeukemiaNet as well as a founding member of the European Working Group for Adult ALL.
Dr Gökbuget has been a coordinator of the German Multicenter Study Group for Adult (GMALL) for over 25 years, acting as principal investigator of several clinical trials in adult ALL and related hematological diseases. She has also established a national ALL registry in Germany.
In her research, Dr Gökbuget focuses on several clinical aspects of adult ALL. These include diagnosis,(MRD based) treatment, quality of life outcomes, late effects and the evaluation of potential new therapies and drugs, in both newlydiagnosed as well as R/R settings.
Related Webinars
Treatment of AYA/adult patients with ALL: focus on the role of asparaginase
Treating adolescents and young adults with ALL and the central role of asparginase